Exploring the intersection of hepatitis C virus and sex work, examining transmission risks, research findings, and public health strategies.
Explore groundbreaking discoveries showing hepatitis C virus persists beyond the liver, revolutionizing treatment approaches and understanding of this complex infection.
Explore how pegylated interferon plus ribavirin therapy proved effective for hepatitis C genotype 6, a regional variant predominantly affecting Southeast Asian populations.
A quiet revolution in public health is making lifesaving hepatitis C treatment more accessible than ever through task-shifting to community-based providers.
Real-world evidence shows glecaprevir/pibrentasvir effectively cures hepatitis C in patients on opioid substitution therapy, advancing HCV elimination efforts.
Understanding occult hepatitis C virus (HCV) infection, a stealthy form of hepatitis C that evades conventional detection methods while possibly still causing harm.
Discover how ledipasvir and sofosbuvir are achieving cure rates above 95% for hepatitis C in patients coinfected with HIV, transforming treatment outcomes.
Exploring the complex relationship between hepatitis C cure and persistent hepatocellular carcinoma risk, including key scientific discoveries and clinical implications.
Discover how hepatitis C virus stimulates murine CD8α-like dendritic cells to produce type I interferon in a TRIF-dependent manner, revealing new insights into antiviral immunity.
Exploring how combining Chinese herbal therapy with peginterferon improves virological response rates in chronic hepatitis C patients.